Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 3
2015 2
2016 3
2017 1
2018 5
2019 3
2020 8
2021 4
2022 7
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

42 results

Results by year

Filters applied: . Clear all
Page 1
Immunological Backbone of Uveal Melanoma: Is There a Rationale for Immunotherapy?
Rossi E, Schinzari G, Zizzari IG, Maiorano BA, Pagliara MM, Sammarco MG, Fiorentino V, Petrone G, Cassano A, Rindi G, Bria E, Blasi MA, Nuti M, Tortora G. Rossi E, et al. Among authors: zizzari ig. Cancers (Basel). 2019 Jul 26;11(8):1055. doi: 10.3390/cancers11081055. Cancers (Basel). 2019. PMID: 31357439 Free PMC article. Review.
CAR-T cells: the long and winding road to solid tumors.
D'Aloia MM, Zizzari IG, Sacchetti B, Pierelli L, Alimandi M. D'Aloia MM, et al. Among authors: zizzari ig. Cell Death Dis. 2018 Feb 15;9(3):282. doi: 10.1038/s41419-018-0278-6. Cell Death Dis. 2018. PMID: 29449531 Free PMC article. Review.
Immune-related toxicity and soluble profile in patients affected by solid tumors: a network approach.
Botticelli A, Cirillo A, Pomati G, Cortesi E, Rossi E, Schinzari G, Tortora G, Tomao S, Fiscon G, Farina L, Scagnoli S, Pisegna S, Ciurluini F, Chiavassa A, Amirhassankhani S, Ceccarelli F, Conti F, Di Filippo A, Zizzari IG, Napoletano C, Rughetti A, Nuti M, Mezi S, Marchetti P. Botticelli A, et al. Among authors: zizzari ig. Cancer Immunol Immunother. 2023 Jul;72(7):2217-2231. doi: 10.1007/s00262-023-03384-9. Epub 2023 Mar 3. Cancer Immunol Immunother. 2023. PMID: 36869232 Free PMC article.
MGL Receptor and Immunity: When the Ligand Can Make the Difference.
Zizzari IG, Napoletano C, Battisti F, Rahimi H, Caponnetto S, Pierelli L, Nuti M, Rughetti A. Zizzari IG, et al. J Immunol Res. 2015;2015:450695. doi: 10.1155/2015/450695. Epub 2015 Dec 29. J Immunol Res. 2015. PMID: 26839900 Free PMC article. Review.
Monoclonal antibodies in gynecological cancer: a critical point of view.
Bellati F, Napoletano C, Gasparri ML, Visconti V, Zizzari IG, Ruscito I, Caccetta J, Rughetti A, Benedetti-Panici P, Nuti M. Bellati F, et al. Among authors: zizzari ig. Clin Dev Immunol. 2011;2011:890758. doi: 10.1155/2011/890758. Epub 2011 Dec 26. Clin Dev Immunol. 2011. PMID: 22235224 Free PMC article. Review.
Circulating CD137+ T Cell Levels Are Correlated with Response to Pembrolizumab Treatment in Advanced Head and Neck Cancer Patients.
Cirillo A, Zizzari IG, Botticelli A, Strigari L, Rahimi H, Scagnoli S, Scirocchi F, Pernazza A, Pace A, Cerbelli B, d'Amati G, Marchetti P, Nuti M, Rughetti A, Napoletano C. Cirillo A, et al. Among authors: zizzari ig. Int J Mol Sci. 2023 Apr 12;24(8):7114. doi: 10.3390/ijms24087114. Int J Mol Sci. 2023. PMID: 37108276 Free PMC article.
42 results